increased slightly between 2021 and 2024, but their uptake remained limited, with *ONLY 3%* of eligible patients having ever received a prescription during that period." "Low adoption and disparities in use likely reflect both system-level access barriers and patient-level demand, including narrow eligibility, limited insurance coverage, and financial considerations that may lead some individuals to forgo treatment after prescription." *NOTE: "did not include prescriptions from online-only pharmacies" and "products for diabetes were excluded" #obesity #medication #treatment #GLP1 #semaglutide #tirzepatide More from this author THE FOX ON THE CAMERA, THE CHICKENS IN ARMOR: A COVID-19 analogy for workplace testing DONT GET TESTY PART 3
And if you're wondering where to get the best treatment, LaserAway is the number one provider of Rejuran in the U.S., offering two next-level add-ons: Rejuran Healing Essence and Rejuran Tone Up Booster
Keratin is intertwined and held together by bonds, including disulfide and hydrogen bonds, determining hairs shape and strength
Perhaps most concerning, 55% of researchers who microdose make the decision without consulting a physician
There are many oral and injectable options now that are FDA-approved, so its best to stick with medications that have been assessed by the standard safety/efficacy channels. If you do decide to use a compounded medication, make sure you work with a qualified medical provider
For a broader survey of this compound class, see our comparative overview of recovery and tissue-repair peptides